Corporate Banner
Satellite Banner
Technology Networks Header
Friday, October 31, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Roche NimbleGen Introduces Advanced RNA-Seq Target Enrichment Tools
Friday, October 31, 2014
The SeqCap RNA target enrichment system for in-depth transcriptome studies.

GE Healthcare Life Sciences’ Dharmacon Launches Innovative Gene Engineering Platform
Thursday, October 30, 2014
Novel toolset substantially decreases time needed to create permanent CRISPR-Cas9-induced genetic changes in cells.

PerkinElmer Launches Mantra™ Quantitative Pathology Imaging System
Tuesday, October 28, 2014
New imaging system enables researchers to visualize, quantify, analyze and phenotype multiple types of immune cells simultaneously in solid tumors.

Production Line Clean Air Solution Launches to Pharma Industry Interest
Friday, October 17, 2014
A unique new product, set to minimise the costs associated with manufacturing drug packaging to GMP standards, has received great interest since its launch at a UK trade event.

Era7 Launches its New Service Genome7
Wednesday, October 15, 2014
An integrated solution for Cancer Genomics.

3D Triculture Model for Evaluating Breast Cancer Progression
Wednesday, October 01, 2014
New application note introduces a more predictive and realistic model for drug screening of cancer therapeutics.

Easy and Cost-Effective Generation of siRNAs from Full-Length Target Genes
Wednesday, September 24, 2014
Dicer siRNA generation kit from AMSBIO.

Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
Friday, September 12, 2014
Idylla™’s first test identifies cancers driven by the BRAF oncogene. Cancer patients will benefit significantly from faster therapy decisions and better guidance of treatment choices.

Meet SeedEZ, a universal 3D cell culture drug screening system
Sunday, September 07, 2014
Lena Biosciences introduces a robust and easy to use SeedEZ 3D cell culture drug screening system supporting consistent yet complex 3D cell culture, co-culture and multilayered tissue models with immune and inflammatory components.

<< 1 2 3 4 5 6 7 >>
Showing Results 1 - 10 of 658
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv